Aon (NYSE:AON) Stock

Aon is a leading global provider of insurance and reinsurance brokerage and human resources solutions. Its operations are tilted toward its brokerage operations. Headquartered in London, Aon has about 50,000 employees and operations in over 120 countries.

visa shutter2

News

Upgrades

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

COMM

This Visa Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

January,24,,2024,,Fort,Worth,,Tx,,Usa:,A,Closed,Box

Biotech

Large Cap

Health Care

General

Eli Lilly&#39;s Zepbound is challenging Wegovy in the obesity market, while U.S. health care costs are set to rise 9% in 2025, driven by specialty drugs and inflation.

US Employer Health Costs To Rise In 2025 Fueled By Weight Loss: Report

Nio Photo by Sundry Photography on Shutterstock

NTNX

This Nio Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Aon plc Class A Ordinary Shares (Ireland)

Aon PLC

AMER ONCOLOGY NETWORK A by American Oncology Network, Inc.

American Oncology Network Inc

American Oncology Network Inc Warrants (31/03/2028)

AEON Co Ltd

Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) has outperformed the market over the past 15 years by 4.25% on an annualized basis producing an average annual return of 16.28%. Currently, Aon has a market capitalization of $84.47 billion. 
Buying $100 In AON: If an investor had bought $100 of AON stock 15 years ago, it would be worth $957.64 today based on a price of $391.05 for AON at the time of writing.
<h3>Aon's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739547008_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

Aon's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) short percent of float has fallen 3.26% since its last report. The company recently reported that it has 4.45 million shares sold short, which is 2.08% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.67 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Aon Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739368821_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Aon has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Aon's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Aon's peer group average for short interest as a percentage of float is 2.46%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Aon's Recent Short Interest

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) with a Outperform and raises the price target from $411 to $414.

Price Target

Keefe, Bruyette & Woods Maintains Outperform on Aon, Raises Price Target to $414

Piper Sandler analyst Paul Newsome maintains Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) with a Neutral and raises the price target from $372 to $384.

Piper Sandler Maintains Neutral on Aon, Raises Price Target to $384

RBC Capital analyst Scott Heleniak maintains Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) with a Sector Perform and raises the price target from $390 to $400.

RBC Capital Maintains Sector Perform on Aon, Raises Price Target to $400

Wells Fargo analyst Elyse Greenspan maintains Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) with a Overweight and raises the price target from $410 to $445.

Wells Fargo Maintains Overweight on Aon, Raises Price Target to $445

Guidance

Aon Introduces 2025 Guidance To Deliver Mid-Single-Digit Or Greater Organic Revenue Growth, Adjusted Margin Expansion, Strong Adjusted EPS Growth And Double-Digit Free Cash Flow Growth

Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) reported quarterly earnings of $4.42 per share which beat the analyst consensus estimate of $4.25 by 4 percent. This is a 13.62 percent increase over earnings of $3.89 per share from the same period last year. The company reported quarterly sales of $4.15 billion which missed the analyst consensus estimate of $4.20 billion by 1.31 percent. This is a 22.87 percent increase over sales of $3.38 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

Aon Q4 2024 Adj EPS $4.42 Beats $4.25 Estimate, Sales $4.15B Miss $4.20B Estimate

<h3>Companies Reporting Before The Bell</h3>
• Novartis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) is estimated to report quarterly earnings at $1.79 per share on revenue of $12.77 billion. 
• Zapp Electric Vehicles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZAPP#NASDAQ">ZAPP</a>) is projected to report earnings for its Fiscal Year 2024. 
• Dorian LPG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPG#NYSE">LPG</a>) is estimated to report quarterly earnings at $0.70 per share on revenue of $89.89 million. 
• Piper Sandler (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PIPR#NYSE">PIPR</a>) is projected to report quarterly earnings at $3.96 per share on revenue of $452.49 million. 
• WisdomTree (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>) is projected to report quarterly earnings at $0.18 per share on revenue of $111.06 million. 
• RBC Bearings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBC#NYSE">RBC</a>) is estimated to report quarterly earnings at $2.20 per share on revenue of $394.43 million. 
• OneMain Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMF#NYSE">OMF</a>) is projected to report quarterly earnings at $1.15 per share on revenue of $1.20 billion. 
• W.W. Grainger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWW#NYSE">GWW</a>) is likely to report quarterly earnings at $9.74 per share on revenue of $4.24 billion. 
• Virtus Inv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRTS#NYSE">VRTS</a>) is likely to report quarterly earnings at $7.66 per share on revenue of $214.69 million. 
• Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) is expected to report quarterly earnings at $2.82 per share on revenue of $6.36 billion. 
• Imperial Oil (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IMO#AMEX">IMO</a>) is likely to report quarterly earnings at $2.02 per share on revenue of $13.18 billion. 
• First Hawaiian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FHB#NASDAQ">FHB</a>) is estimated to report quarterly earnings at $0.41 per share on revenue of $203.83 million. 
• Broadridge Financial Soln (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BR#NYSE">BR</a>) is estimated to report quarterly earnings at $1.35 per share on revenue of $1.57 billion. 
• Vestis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) is likely to report quarterly earnings at $0.12 per share on revenue of $688.89 million. 
• Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) is expected to report quarterly earnings at $1.79 per share on revenue of $88.23 billion. 
• Revvity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVTY#NYSE">RVTY</a>) is expected to report quarterly earnings at $1.38 per share on revenue of $730.10 million. 
• Janus Henderson Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHG#NYSE">JHG</a>) is projected to report quarterly earnings at $0.97 per share on revenue of $683.02 million. 
• Church &amp; Dwight Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHD#NYSE">CHD</a>) is estimated to report quarterly earnings at $0.76 per share on revenue of $1.57 billion. 
• Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) is estimated to report quarterly earnings at $4.26 per share on revenue of $4.21 billion. 
• Badger Meter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMI#NYSE">BMI</a>) is expected to report quarterly earnings at $1.07 per share on revenue of $201.60 million. 
• Franklin Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>) is likely to report quarterly earnings at $0.56 per share on revenue of $2.73 billion. 
• Autoliv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) is expected to report quarterly earnings at $2.85 per share on revenue of $2.73 billion. 
• LyondellBasell Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) is likely to report quarterly earnings at $0.95 per share on revenue of $9.49 billion. 
• Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) is likely to report quarterly earnings at $0.94 per share on revenue of $35.07 billion. 
• Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) is expected to report quarterly earnings at $2.40 per share on revenue of $48.68 billion. 
• Charter Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) is estimated to report quarterly earnings at $9.18 per share on revenue of $13.89 billion. 
• Brookfield Business (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBUC#NYSE">BBUC</a>) is likely to report earnings for its fourth quarter. 
• Brookfield Bus Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBU#NYSE">BBU</a>) is estimated to report earnings for its fourth quarter. 
• Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEPC#NYSE">BEPC</a>) is likely to report quarterly loss at $0.36 per share on revenue of $2.01 billion. 
• Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEP#NYSE">BEP</a>) is expected to report quarterly loss at $0.35 per share on revenue of $1.53 billion. 
• ArcBest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) is estimated to report quarterly earnings at $1.12 per share on revenue of $1.01 billion. 
• Gentex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNTX#NASDAQ">GNTX</a>) is likely to report quarterly earnings at $0.48 per share on revenue of $598.58 million. 
• AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) is estimated to report quarterly earnings at $2.98 per share on revenue of $14.81 billion. 
• Banco De Chile (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCH#NYSE">BCH</a>) is projected to report quarterly earnings at $0.53 per share on revenue of $804.00 billion. 
• Booz Allen Hamilton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) is expected to report quarterly earnings at $1.51 per share on revenue of $2.86 billion. 
• Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) is likely to report quarterly earnings at $0.90 per share on revenue of $5.05 billion. 
<h3>Companies Reporting After The Bell</h3>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABBV

ARCB

BBUC

BEPC

CHTR

GNTX

Janus Henderson Group plc Ordinary Shares

PIPR

RVTY

VRTS

VSTS

ZAPP

Earnings Scheduled For January 31, 2025

Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) has outperformed the market over the past 10 years by 3.45% on an annualized basis producing an average annual return of 14.88%. Currently, Aon has a market capitalization of $80.55 billion. 
Buying $1000 In AON: If an investor had bought $1000 of AON stock 10 years ago, it would be worth $4,044.42 today based on a price of $372.48 for AON at the time of writing.
<h3>Aon's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738159209_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) has outperformed the market over the past 15 years by 3.82% on an annualized basis producing an average annual return of 16.09%. Currently, Aon has a market capitalization of $78.87 billion. 
Buying $1000 In AON: If an investor had bought $1000 of AON stock 15 years ago, it would be worth $9,345.72 today based on a price of $364.67 for AON at the time of writing.
<h3>Aon's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737675009_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

Aon's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) short percent of float has risen 6.47% since its last report. The company recently reported that it has 4.57 million shares sold short, which is 2.14% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.97 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Aon Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737126911_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Aon has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Aon's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Aon's peer group average for short interest as a percentage of float is 2.96%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Aon?

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Baird analyst Mircea Dobre upgraded the rating for United Rentals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>) from Underperform to Neutral and maintained the price target of $658. United Rentals shares closed at $689.15 on Monday. <a href="https://www.benzinga.com/quote/URI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan analyst Samik Chatterjee upgraded CommScope Holding Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COMM#NASDAQ">COMM</a>) from Underweight to Neutral and announced a $5 price target. CommScope shares closed at $4.92 on Monday. <a href="https://www.benzinga.com/quote/COMM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Seaport Global analyst Jeff Cantwell upgraded the rating for Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) from Neutral to Buy. Visa shares closed at $306.92 on Monday. <a href="https://www.benzinga.com/quote/V/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities analyst Michael Feniger upgraded Cummins Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) from Underperform to Neutral and raised the price target from $354 to $358. Cummins shares closed at $361.07 on Monday. <a href="https://www.benzinga.com/quote/CMI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo analyst Elyse Greenspan upgraded the rating for Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) from Equal-Weight to Overweight and raised the price target from $377 to $410. Aon shares closed at $354.68 on Monday. <a href="https://www.benzinga.com/quote/AON/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying Visa stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="552" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14085533/image-87-1024x552.png" alt="" class="wp-image-732467" style="width:567px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14085533/image-87-1024x552.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14085533/image-87-300x162.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14085533/image-87-768x414.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14085533/image-87.png 1140w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/42965686/top-2-industrials-stocks-that-may-fall-off-a-cliff-in-january">Top 2 Industrials Stocks That May Fall Off A Cliff In January</a></li>
</ul>

Wells Fargo analyst Elyse Greenspan upgrades Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) from Equal-Weight to Overweight and raises the price target from $377 to $410.

Wells Fargo Upgrades Aon to Overweight, Raises Price Target to $410

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) with a Outperform and lowers the price target from $415 to $411.

Keefe, Bruyette & Woods Maintains Outperform on Aon, Lowers Price Target to $411

Evercore ISI Group analyst David Motemaden upgrades Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) from In-Line to Outperform and raises the price target from $407 to $420.

Evercore ISI Group Upgrades Aon to Outperform, Raises Price Target to $420

Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) has outperformed the market over the past 15 years by 4.59% on an annualized basis producing an average annual return of 16.05%. Currently, Aon has a market capitalization of $76.77 billion. 
Buying $100 In AON: If an investor had bought $100 of AON stock 15 years ago, it would be worth $936.87 today based on a price of $354.98 for AON at the time of writing.
<h3>Aon's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735912809_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Aon 15 Years Ago Would Be Worth Today

JP Morgan analyst Jimmy Bhullar maintains Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) with a Overweight and raises the price target from $379 to $394.

JP Morgan Maintains Overweight on Aon, Raises Price Target to $394

Eli Lilly and Co.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) Zepbound (tirzepatide) is reshaping the competitive landscape in obesity treatment, challenging Novo Nordisk A/S' (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) Wegovy (semaglutide) for market dominance.
According to a GlobalData <a target="_blank" href="https://www.globaldata.com/media/pharma/eli-lillys-zepbound-holds-potential-dominate-obesity-market-says-globaldata/" rel="noreferrer noopener">report</a>, Zepbound's superior effectiveness and strategic market growth position it to potentially overtake Wegovy as the <a target="_blank" href="https://www.benzinga.com/24/12/42613036/novo-nordisks-hybrid-weight-loss-drug-falls-short-on-expectations-stock-plunges" rel="noreferrer noopener">leading therapy for obesity</a>.
Since its debut, Zepbound has expanded its scope beyond obesity treatment. In December 2024, the FDA approved the drug for treating <a target="_blank" href="https://www.benzinga.com/general/health-care/24/12/42637278/eli-lillys-zepbound-receives-fda-approval-for-obesity-linked-sleep-apnea-drug" rel="noreferrer noopener">obstructive sleep apnea</a>.
Ongoing studies are exploring additional indications, such as reducing cardiovascular risks, addressing chronic kidney disease, and treating metabolic dysfunction-associated steatohepatitis (MASH).
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/12/42600472/your-healthcare-costs-are-soaring-us-spending-reached-5-trillion-in-2023-with-major-increase-in-obesity-and-diabetes-drugs-hospital-services" rel="noreferrer noopener">Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services</a>.
GlobalData's Pharma Analyst, Costanza Alciati, highlighted that Eli Lilly is emulating Novo Nordisk's approach by exploring multiple therapeutic areas to broaden Zepbound's market potential.
Wegovy has been a game-changer in the obesity sector, earning widespread recognition and driving significant investment in the field. Over 400 companies are now developing obesity therapies inspired by Wegovy's success. The drug is also approved for managing type 2 diabetes and cardiovascular risks, with further research focusing on conditions like chronic kidney disease.
Despite Wegovy's achievements, Alciati remarked that Zepbound is "raising the bar" with greater potency and potential cost-effectiveness, making it a formidable contender in the obesity market.
In parallel, healthcare costs in the U.S. are climbing rapidly. Aon plc's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) August <a target="_blank" href="https://aon.mediaroom.com/2024-08-15-Aon-U-S-Employer-Health-Care-Costs-Projected-to-Increase-9-Percent-Next-Year" rel="noreferrer noopener">report</a> projects a 9% increase in employer-sponsored healthcare costs for 2025, exceeding $16,000 per employee.
This surge surpasses the 6.4% rise from 2023 to 2024, driven by higher medical claims, rising prescription drug expenses, and inflation-related adjustments.
Specialty drugs, particularly GLP-1 medications like tirzepatide and semaglutide, are key drivers of these rising costs. Aon's analysis reveals that these medications could add 1% to overall healthcare cost increases.
Despite their low utilization, these therapies significantly impact employer healthcare budgets.
On average, U.S. employers cover 81% of health plan costs, leaving employees to pay 19%, amounting to $4,858 annually, including premiums and out-of-pocket expenses.
In 2024, employer healthcare budgets grew by 6.4%, while employee premiums increased by a more modest 3.4%, according to Aon's analysis.
The technology and communications sector experienced the highest employer cost increase at 7.4% in 2024, while public sector employees faced the steepest rise in contributions at 6.7%.
In contrast, the healthcare industry saw no material change in employee contributions.
High-cost claims stemming from gene and cell therapies, complex medical procedures, and chronic conditions further strain employer budgets.
Price Action: LLY stock is up 0.88% at $778.79 during the premarket session at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/contracts/25/01/42763712/arcos-dorados-renews-franchise-agreement-with-mcdonalds-stock-gains" target="_blank" rel="noreferrer noopener">Arcos Dorados Renews Franchise Agreement With McDonald's, Stock Gains</a></li>
</ul>
Photo by Ciara Kimsey via Shutterstock

Aon's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) short percent of float has fallen 10.27% since its last report. The company recently reported that it has 4.29 million shares sold short, which is 2.01% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.38 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Aon Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735587010_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Aon has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Aon's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Aon's peer group average for short interest as a percentage of float is 3.02%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(AON) - Analyzing Aon's Short Interest

Insurance

Press Releases

WOODWARD PARK PARTNERS ADVISES SALUS GROUP IN ITS SALE TO NFP, A WHOLLY OWNED SUBSIDIARY OF AON

Canadian defined benefit pension plans show slightly decreased funded levels in Q4: Aon

Aon appoints John Neal as Global Chairman of Climate Solutions and Global CEO of Reinsurance

Aon Announces Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Dividends

Aon Announces Quarterly Cash Dividend

Sixty Percent of Employees Plan to Move Jobs This Year, Aon Study Finds

Q1 2025 Insurance Labor Market Study Now Open for Participation

Greater Insurability of Climate Risk is Key to Global Economic Resilience: Aon Catastrophe Report

Aon Reports Fourth Quarter and Full Year 2024 Results

Q1 2025 Insurance Labor Market Study Results to be Highlighted in Webinar

Abacus Life

Arthur J. Gallagher

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Health In Tech, Inc. - Class A Common Stock

Health In Tech

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan

Reliance Global Group, Inc. - Common Stock

Reliance Global Group

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Comments

Aon

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga